{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fraisinghealth.simplecast.com%2Fepisodes%2Fadapting-biopharma-to-ai-with-greg-meyers-ywdwXVvZ","width":444,"version":"1.0","type":"rich","title":"Adapting Biopharma to AI with Greg Meyers","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/8bfdd457-9cd9-4577-bbed-a027587c6960/103ea12d-dd5b-4ef8-b398-ddf54dfbe24e/cover-art-3000x3000-no-grain-2.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/09283bc1-9e4e-40fe-829a-b8db57c9c112\" height=\"200\" width=\"100%\" title=\"Adapting Biopharma to AI with Greg Meyers\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Greg Meyers, EVP and Chief Digital and Technology Officer at Bristol Myers Squibb (or BMS), joins a16z Bio + Health general partner Jorge Conde."}